On 15th October, I presented at a three-day conference at Linkoping University in Sweden on Life with Dementia 2014: Relations. There were two strands to the conference: communication and citizenship and I predominantly attended the citizenship parallel sessions as this is where I am currently focused. The conference was attended by delegates from universities in Sweden, the UK, Norway, Japan, Canada and USA, all with an interest in working and campaigning to promote the rights and inclusion of people with dementia as equal citizens or partners in interaction. In the citizenship strand, there were presentations and key notes with questions and ideas on what citizenship and rights means in the context of people with dementia, with a particular challenge of what it means for people with more severe cognitive impairment. Throughout the conference, we heard, or spoke, about interdependence, human capabilities, opportunities rather than support, inclusive research methods, co-researching, parity of participation and transformative strategies to reduce social injustice. At the end of the conference, there was a separate meeting to work on capturing the enthusiasm and commitment to ensuring people with dementia remain equal citizens, so we formed the ‘citizenship and dementia international research network’, with a view to collaborating on writing, presenting at conferences, campaigning and working on research ideas. Anyone interested in hearing more, please get in touch fkelly@bournemouth.ac.uk











BU PhD student attending HIV conference on scholarship
ESRC SWDTP – Applications open for PhD Studentships for September 2026
New paper by CMWH PhD student
Further CMWH contributions to 2026 ICM congress
ECR Funding Open Call: Research Culture & Community Grant – Apply Now
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Horizon Europe 2025 Work Programme pre-Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease